The lack or reduced expression of RUNX1 also affects the activity of MYB, MYC, and GATA3 oncogenes, which confirms the key role of RUNX1 in the pathogenesis of T-ALL (24). This evidence concerns the gene GATA3 and acute lymphoblastic leukemia.